Page last updated: 2024-08-26

cp-55,940 and gw 842166x

cp-55,940 has been researched along with gw 842166x in 4 studies

Research

Studies (4)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (25.00)29.6817
2010's3 (75.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Futaki, N; Iida, I; Ishizaka, T; Ohta, H; Saito, S; Tatsuzuki, M; Toda, Y; Tomishima, Y; Yamaguchi, T; Yoshinaga, M1
Chen, JZ; Chen, LL; Han, S; Pu, JB; Qian, HY; Xie, X; Zhang, FF2
Chen, JZ; Li, GJ; Pan, YL; Qian, HY; Wang, ZL; Xie, X; Xie, XY1

Other Studies

4 other study(ies) available for cp-55,940 and gw 842166x

ArticleYear
Imine derivatives as new potent and selective CB2 cannabinoid receptor agonists with an analgesic action.
    Bioorganic & medicinal chemistry, 2008, Feb-01, Volume: 16, Issue:3

    Topics: Animals; Humans; Imines; Male; Molecular Structure; Pyrazoles; Rats; Rats, Sprague-Dawley; Receptor, Cannabinoid, CB2; Structure-Activity Relationship

2008
Design, syntheses, structure-activity relationships and docking studies of coumarin derivatives as novel selective ligands for the CB2 receptor.
    European journal of medicinal chemistry, 2015, Mar-26, Volume: 93

    Topics: Animals; Calcium; CHO Cells; Coumarins; Cricetulus; Drug Design; Ligands; Molecular Docking Simulation; Molecular Structure; Receptor, Cannabinoid, CB1; Receptor, Cannabinoid, CB2; Structure-Activity Relationship; Transfection

2015
Development of Quinoline-2,4(1H,3H)-diones as Potent and Selective Ligands of the Cannabinoid Type 2 Receptor.
    Journal of medicinal chemistry, 2015, Aug-13, Volume: 58, Issue:15

    Topics: Animals; CHO Cells; Cricetinae; Cricetulus; Disease Models, Animal; Encephalomyelitis, Autoimmune, Experimental; Female; Ligands; Mice; Mice, Inbred C57BL; Molecular Docking Simulation; Multiple Sclerosis; Quantitative Structure-Activity Relationship; Quinolines; Receptor, Cannabinoid, CB2

2015
Developing pyridazine-3-carboxamides to be CB2 agonists: The design, synthesis, structure-activity relationships and docking studies.
    European journal of medicinal chemistry, 2017, Sep-08, Volume: 137

    Topics: Animals; CHO Cells; Cricetulus; Dose-Response Relationship, Drug; Humans; Molecular Docking Simulation; Molecular Structure; Pyridazines; Receptor, Cannabinoid, CB2; Structure-Activity Relationship

2017